Sponsor of the Day:
Jerkmate
https://www.genengnews.com/topics/cancer/novel-antibody-technologies-strive-for-clinical-impact/
Novel Antibody Technologies Strive for Clinical Impact
Mar 10, 2026 - From penetrating solid tumors to new success rates for de novo design, the next wave of antibody therapies aims to transform the clinic.
novel antibodyclinical impacttechnologiesstrive
https://www.prnewswire.co.uk/news-releases/k-679-a-novel-antibody-drug-loaded-unimicelle-conjugate-demonstrates-tumor-selective-pharmacokinetics-extensive-intratumoral-distribution-and-superior-efficacy-in-non-clinical-animal-models-302729067.html
K-679: A Novel Antibody Drug-loaded Unimicelle Conjugate Demonstrates Tumor-Selective...
Apr 6, 2026 - /PRNewswire/ -- Kowa Company, Ltd. (Headquarters: Nagoya, Aichi Prefecture, Japan), today announced an upcoming presentation of non-clinical data for K‑679,...
novel antibodyk679drugloaded
https://www.newswire.ca/news-releases/k-679-a-novel-antibody-drug-loaded-unimicelle-conjugate-demonstrates-tumor-selective-pharmacokinetics-extensive-intratumoral-distribution-and-superior-efficacy-in-non-clinical-animal-models-802145429.html
K-679: A Novel Antibody Drug-loaded Unimicelle Conjugate Demonstrates Tumor-Selective...
Apr 6, 2026 - /CNW/ -- Kowa Company, Ltd. (Headquarters: Nagoya, Aichi Prefecture, Japan), today announced an upcoming presentation of non-clinical data for K‑679, its...
novel antibodyk679drugloaded
https://www.newswise.com/articles/first-in-class-radio-theranostic-utilizes-novel-antibody-developed-at-ut-md-anderson
First-in-Class Radio-Theranostic Utilizes Novel Antibody Developed at UT MD Anderson | Newswise
Apr 1, 2026 - Study details the development of a novel antibody that targets a specific type of B7-H3, a protein overexpressed in many cancers Study details the development...
ut md andersonnovel antibodyfirstclassradio
https://www.thepharmanavigator.com/news/abbvie-remegen-sign-exclusive-licensing-agreement-for-novel-bispecific-antibody
AbbVie, RemeGen Sign Exclusive Licensing Agreement for Novel Bispecific Antibody — The Pharma...
Jan 14, 2026 - The agreement will allow AbbVie to develop, manufacture, and commercialize RemeGen’s novel PD-1/VEGF bispecific antibody in combination with its ADCs across...
sign exclusivelicensing agreementbispecific antibodyabbvienovel
https://www.max-planck-innovation.com/technology-offers/technology-offer/monoclonal-antibody-to-detect-neutrophil-extracellular-traps-via-a-novel-post-translational-histone-modification-2.html
Monoclonal Antibody to Detect Neutrophil Extracellular Traps via a Novel Post Translational Histone...
A novel tool to detect and quantify NETs using a molecular feature of NET formation that has never been proposed as a marker for NETs before
monoclonal antibodypost translationaldetectneutrophilextracellular